Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecuti
- PDF / 1,265,556 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 35 Downloads / 203 Views
ORIGINAL ARTICLE
Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols Eric J. Monroe 1,2 & Jeffrey Forris Beecham Chick 1,2 & Andrew W. Stacey 3 & Nathan E. Millard 4 & J. Russell Geyer 4 & L. Ray Ramoso 1 & Basavaraj V. Ghodke 5 & Danial K. Hallam 5 Received: 27 May 2020 / Revised: 27 September 2020 / Accepted: 19 October 2020 # Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Background Intra-arterial chemotherapy (IAC) represents a mainstay of retinoblastoma treatment in children. Patients with retinoblastoma are uniquely at risk for secondary malignancies and are sensitive to the ionizing effects of radiation. Objective To retrospectively review a single institution’s experience with IAC for retinoblastoma and the effect of variable intraprocedural imaging techniques on radiation exposure. Materials and methods Twenty-four consecutive patients, with a mean age of 30.8±16.3 months (range: 3.2–83.4 months), undergoing IAC for retinoblastoma between May 2014 and May 2020 (72 months) were included. No patients were excluded. The primary outcome was radiation exposure and secondary outcomes included technical success and procedural adverse events. Technical success was defined as catheterization of the ophthalmic or meningolacrimal artery and complete delivery of chemotherapy. Each procedure was retrospectively reviewed and categorized as one of five imaging protocol types. Protocol types were characterized by uniplanar versus multiplanar imaging and digital subtraction angiographic versus roadmap angiographic techniques. Radiation exposure, protocol utilization, the association of protocol and radiation exposure were assessed. Results During 96 consecutive interventions, 109 ocular treatments were performed. Thirteen of the 96 (15.5%) treatments were bilateral. Ocular technical success was 106 of 109 (97.2%). All three treatment failures were successfully repeated within a week. Mean fluoroscopy time was 6.4±6.2 min (range: 0.7–31.1 min). Mean air kerma was 36.2±52.2 mGy (range: 1.4–215.0 mGy). There were two major (1.8%) complications and four (3.7%) minor complications. Of the 96 procedures, 10 (10.4%), 9 (9.4%), 13 (13.5%), 28 (29.2%) and 36 (37.5%) were performed using protocol types A, B, C, D and E, respectively. For protocol type A, mean fluoroscopy time was 10.3±6.8 min (range: 3.0–25.4 min) and mean air kerma was 118.2±61.2 mGy (range: 24.5– 167.3 mGy). For protocol type E, mean fluoroscopy time was 3.1±3.2 min (range: 0.7–15.1 min) and mean air kerma was 5.4 ±4.2 mGy (range: 1.4–19.5 mGy). Fluoroscopy time and air kerma decreased over time, corresponding to the reduced use of multiplanar imaging and digital subtraction angiography. In the first quartile (procedures 1–24), 8 (33.3%), 7 (29.2%), 2 (8.3%), 6 (25.0%) and 1 (4.2%) were performed using protocol types A, B, C, D and E, respectively. Mean fluoroscopy time was 10.5 ±8.2 min (range: 2.4–28.1 min) and mean
Data Loading...
